Fundraising Fox
/Companies
Sign in

TheraVida

Chapel Hill, US · Founded 2007 · 1 known investors

Find your way into TheraVida

Sign up to see every warm intro you have to TheraVida

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TheraVida team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating). Its patent-protected technology aims to improve tolerability over existing treatments while maintaining efficacy.

BiotechHealthtechMedical Devices

Founders & leadership

BF
Benjamin F. McGrawCEO & Chairman
RD
Rhonda DonahoeCFO
AK
Assad KazeminyVP, Business Development
MP
Mehdi PaborjiExecutive
RL
Roger L. FlugelExecutive
RS
Roger S. FlugelExecutive

Board

NJ
Nasser J. KazeminyBoard director
FAFred A. Middleton
Fred A. MiddletonBoard directorManaging Director at Sanderling Ventures
BFBenjamin F. McGraw III
Benjamin F. McGraw IIIBoard directorVenture Partner at Sanderling Ventures

Investors · 1

Reported raises · per SEC filings

Form D private placements

$9.1M disclosed across 2 rounds · 2010–2023

▶$200KraisedFeb 2023 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nasser J. KazeminyDirector
  • Fred A. MiddletonDirector
  • Benjamin F. McGraw IIIExecutive Officer, Director
Offering amount
$200K
Amount sold
$200K
First sale
Jan 2023
Incorporated
Corporation, North Carolina
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.9MraisedMar 2012 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mehdi PaborjiExecutive Officer, Director
  • Roger L. FlugelExecutive Officer, Director
  • Assad KazeminyDirector
  • Roger S. FlugelExecutive Officer, Director
Offering amount
$12.3M
Amount sold
$8.9M
First sale
Jun 2010
Incorporated
Corporation, Delaware, 2007
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Viridian TherapeuticsViridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
Merida BiosciencesMerida is a biotherapeutics company developing a new class of drugs designed to selectively and durably eliminate the pathogenic antibodies that drive autoimmune and allergic diseases. Its work spans discovery, drug development, and clinical operations aimed at treating patients with these conditions.

Companies working in the same space as TheraVida.

Frequently asked questions

What does TheraVida do?
TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating). Its patent-protected technology aims to improve tolerability over existing treatments while maintaining efficacy.
Who are TheraVida's investors?
TheraVida's investors include Sanderling Ventures.
How much funding has TheraVida raised?
TheraVida has disclosed $9.1M raised across 2 rounds.
Where is TheraVida headquartered?
TheraVida is headquartered in Chapel Hill, US.